Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

about

Evaluation of markers of outcome in real-world treatment of diabetic macular edema

P2860

Q58572470-8CB4DB49-54FD-4071-B248-8D67CE0F3F08

P2860

Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

Item

http://www.wikidata.org/entity/Q36178853

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@ast

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@en

type

Item

label

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@ast

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@en

prefLabel

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@ast

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@en

P1476

Intravitreal bevacizumab injec ...... sponse: a retrospective study.

@en

P2093

Asaf Bar

http://www.w3.org/2001/XMLSchema#string

Jiten Morarji

http://www.w3.org/2001/XMLSchema#string

Lavnish Joshi

http://www.w3.org/2001/XMLSchema#string

Panayiotis Vouzounis

http://www.w3.org/2001/XMLSchema#string

Satish Yaganti

http://www.w3.org/2001/XMLSchema#string

Sophie Seguin-Greenstein

http://www.w3.org/2001/XMLSchema#string

Sue Lightman

http://www.w3.org/2001/XMLSchema#string

P2860

Blood pressure control for diabetic retinopathy

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Five-year visual outcome following laser photocoagulation of diabetic macular oedema.

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.

Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5).

Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4).

P304

2093-2098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S109809

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon R. Taylor

Oren Tomkins-Netzer

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799737

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

5085296

http://www.w3.org/2001/XMLSchema#string

Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

about

P2860

P2860

Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932